首页> 外国专利> METHOD FOR PREDICTING DEVELOPMENT OF PRE-ECLAMPSIAMETHOD FOR PREDICTING DEVELOPMENT OF PRE-ECLAMPSIA IN PREGNANT WOMEN WITH PRIMARY ARTERIAL HYPERTENS IN PREGNANT WOMEN WITH PRIMARY ARTERIAL HYPERTENSION ION

METHOD FOR PREDICTING DEVELOPMENT OF PRE-ECLAMPSIAMETHOD FOR PREDICTING DEVELOPMENT OF PRE-ECLAMPSIA IN PREGNANT WOMEN WITH PRIMARY ARTERIAL HYPERTENS IN PREGNANT WOMEN WITH PRIMARY ARTERIAL HYPERTENSION ION

机译:预测先皮脂血症的发展的方法,以预测原发性高血压的孕妇的先发癫痫的发展

摘要

The method for predicting the development of pre-eclampsia in pregnant women with the primary arterial hypertension comprises the assessment of the immunologic parameters within 20 weeks of gestation. In particular, several cytokines are assayed: interleukin-2, tumor necrosis factor alpha, and interleukin-10. In addition, the natural killers are counted. The increase in interleukin-2 level over 30 pg/ml, the increase in tumor necrosis factor alpha content up to 50.5 pg/ml and above, the decrease in interleukin-10 level below 12.0 pg/ml, and 15% increase in natural killer count are regarded as the prognostic features suggesting the development of pre-eclampsia in the early stages of gestation.
机译:预测患有原发性动脉高血压的孕妇先兆子痫发展的方法包括在妊娠20周内评估免疫学参数。具体而言,测定了几种细胞因子:白介素2,肿瘤坏死因子α和白介素10。此外,还计算了自然杀手。超过30 pg / ml的白细胞介素2水平增加,高达50.5 pg / ml及以上的肿瘤坏死因子α含量增加,低于12.0 pg / ml的白细胞介素10水平降低以及自然杀手的增加15%计数被认为是预兆,提示子痫早期在妊娠早期发展。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号